Science Explorer Back to mapMap
Discussion
Company · San Diego · United States

AntiCancer (United States)

In research, AntiCancer (United States) stands highest in Life Sciences (#5,293 of 11,023 worldwide), Biochemistry, Genetics and Molecular Biology (#2,869 of 5,801 worldwide) and Biotechnology (#206 of 371 worldwide), over all time. Relative to its size it is most specialised in Biochemistry, Genetics and Molecular Biology (Biochemistry, Genetics and Molecular Biology is 10.0× its share of world research).

World rank, all time
#19,105
of 34,923
Rank in United States
#3,966
of 7,310
Research works
579
▼ 36% vs 2018-21
Citations
19k
33.2 per fractional work
Top-10% rate
7.3%
all institutions 10.0%
vs its own fields
1.16×
1.00× is exactly expected
Open access
34%
world 40%
International
45%
world 18%

What is AntiCancer (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #5,293 of 11,023 13.2%351
Biochemistry, Genetics and Molecular BiologyField #2,869 of 5,801 13.6%328
BiotechnologySubfield #206 of 371 14.1%155
Health SciencesDomain #13,689 of 16,688 10.8%148
MedicineField #12,350 of 14,558 11.0%146

Each strip is that field's whole ranked pool, with the notch where AntiCancer (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does AntiCancer (United States) work in?

In 2022-now, 57% of research at AntiCancer (United States) is in Life Sciences, 38% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (53%), Medicine (37%), Engineering (4%). It does 3.4× the world's share of Life Sciences.

Life Sciences: 35 fractional works · 56.5% of its workBiochemistry, Genetics and Molecular Biology: 33 fractional works · 53.1% of its workBiotechnology: 13 fractional works · 21.8% of its workMolecular Biology: 10 fractional works · 16.4% of its workGenetics: 3 fractional works · 4.6% of its workCancer Research: 2 fractional works · 3.6% of its workCell Biology: 2 fractional works · 3.2% of its workBiochemistry: 1 fractional works · 1.5% of its workAging: 1 fractional works · 0.9% of its workBiophysics: 0 fractional works · 0.8% of its workMolecular Medicine: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 1.7% of its workImmunology: 1 fractional works · 1.3% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNeuroscience: 1 fractional works · 1.2% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.5% of its workDevelopmental Neuroscience: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workFood Science: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.1% of its workHealth Sciences: 23 fractional works · 37.5% of its workMedicine: 23 fractional works · 37.4% of its workOncology: 6 fractional works · 10.2% of its workRheumatology: 5 fractional works · 7.4% of its workPulmonary and Respiratory Medicine: 4 fractional works · 6.3% of its workSurgery: 2 fractional works · 2.8% of its workPsychiatry and Mental health: 1 fractional works · 1.8% of its workPathology and Forensic Medicine: 1 fractional works · 1.7% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.3% of its workPhysiology: 1 fractional works · 1.2% of its workGenetics: 1 fractional works · 1.1% of its workUrology: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.6% of its workGastroenterology: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workRehabilitation: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 0 fractional works · 0.2% of its workPhysical Sciences: 4 fractional works · 5.8% of its workEngineering: 3 fractional works · 4.4% of its workBiomedical Engineering: 2 fractional works · 3.8% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 0.5% of its workChemistry: 1 fractional works · 1.1% of its workOrganic Chemistry: 1 fractional works · 1.1% of its workMaterials Science: 0 fractional works · 0.2% of its workComputer Science: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.2% of its workALL ITS WORKAntiCancer(United States)62fractional works, 2022-now
Life Sciences57%Physical Sciences6%Health Sciences38%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3353.1%
    2. Immunology and Microbiology11.7%
    3. Neuroscience11.2%
    4. Agricultural and Biological Sciences00.4%
    5. Pharmacology, Toxicology and Pharmaceutics00.1%
    1. Medicine2337.4%
    2. Health Professions00.2%
    1. Engineering34.4%
    2. Chemistry11.1%
    3. Materials Science00.2%
    4. Computer Science00.1%
    1. Psychology00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does AntiCancer (United States) specialise in?

Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 10.0× the share of its output that it takes of world research.

  1. Biochemistry, Genetics and Molecular BiologyField · 32.8 works10.0×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.08× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 9.96× its world share, 33 worksBiochemistry, Geneti…Immunology and Microbiology: 1.64× its world share, 1 worksImmunology and Micro…Neuroscience: 0.76× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.38× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.72× its world share, 1 worksChemistryComputer Science: 0.02× its world share, 0 worksComputer ScienceEngineering: 0.29× its world share, 3 worksEngineeringMaterials Science: 0.05× its world share, 0 worksMaterials ScienceHealth Professions: 0.07× its world share, 0 worksHealth ProfessionsMedicine: 1.94× its world share, 23 worksMedicinePsychology: 0.06× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 10.0×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology9.96×33 works
  2. Medicine1.94×23 works
  3. Immunology and Microbiology1.64×1 works
  4. Neuroscience0.76×1 works
  5. Chemistry0.72×1 works
  6. Pharmacology, Toxicology and Pharmaceutics0.38×0 works
  7. Engineering0.29×3 works
  8. Agricultural and Biological Sciences0.08×0 works
  9. Health Professions0.07×0 works
  10. Psychology0.06×0 works
  11. Materials Science0.05×0 works
  12. Computer Science0.02×0 works

Who are the top researchers at AntiCancer (United States)?

Ranked on the quality score, Meng Yang, Yuying Tan and Mako Yamamoto lead among researchers whose main affiliation is AntiCancer (United States).

  1. 1 Meng Yang United States · #145,392 worldwide 11k citations · 177 works
  2. 2 Yuying Tan United States · #279,885 worldwide 4.8k citations · 190 works
  3. 3 Mako Yamamoto United States · #399,705 worldwide 3.5k citations · 77 works
  4. 4 Ming Dan Zhao United States · #433,566 worldwide 11k citations · 330 works
  5. 5 Ping Jiang United States · #946,388 worldwide 7k citations · 137 works
  6. 6 Mingxu Xu United States · #1,311,977 worldwide 2.7k citations · 82 works
  7. 7 Zili An United States · #1,356,174 worldwide 2.1k citations · 114 works
  8. 8 Eugene A. Baranov United States · #1,356,672 worldwide 4.8k citations · 59 works
  9. 9 Fuminari Uehara United States · #1,901,551 worldwide 1.6k citations · 96 works
  10. 10 Shukuan Li United States · #1,996,329 worldwide 2.2k citations · 41 works
All ranked researchers at AntiCancer (United States)

What are the most cited papers from AntiCancer (United States)?

The most cited paper from AntiCancer (United States) is "Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force" (Katarina Wolf, Mariska te Lindert, Marina Krause et al., 2013), with 1,427 citations. Next come "A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy" (1,056) and "Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling" (649).

Most cited papers
#PaperReleasedCitations
1 Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force Katarina Wolf, Mariska te Lindert, Marina Krause et al. · The Journal of Cell Biology Open access 24 Jun 2013 1,427
2 A Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy Clemens A. Schmitt, Jordan S. Fridman, Meng Yang et al. · Cell Open access May 2002 1,056
3 Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL–RANK signalling Wei Phin Tan, Weizhou Zhang, Amy Strasner et al. · Nature Open access Feb 2011 649
4 The multiple uses of fluorescent proteins to visualize cancer in vivo Robert M. Hoffman · Nature reviews. Cancer Review 30 Sep 2005 617
5 Orthotopic Metastatic Mouse Models for Anticancer Drug Discovery and Evaluation: a Bridge to the Clinic Robert M. Hoffman · Investigational New Drugs Nov 1999 559
All 59 most cited papers, with filters and sorting

Which keywords describe research at AntiCancer (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Immunotherapy, Gene Therapy, Tumor Targeting, Arginine Deprivation, Bacterial Therapy, Cancer, Reactive Oxygen Species and Cancer Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy17▲ 37×8 topics
  2. Gene Therapy16▲ 136×3 topics
  3. Tumor Targeting16▲ 137×2 topics
  4. Arginine Deprivation14▲ 564×1 topic
  5. Bacterial Therapy14▲ 564×1 topic
  6. Cancer8▲ 9.3×24 topics
  7. Reactive Oxygen Species5▲ 19×4 topics
  8. Nanoparticles5▲ 6.0×5 topics
  9. Cancer Therapy4▲ 13×10 topics
  10. Photodynamic Therapy4▲ 31×3 topics
  11. Cardiovascular Disease4▲ 5.8×2 topics
  12. Folate4▲ 234×1 topic
  13. Homocysteine4▲ 234×1 topic
  14. Metabolism3▲ 9.9×6 topics
  15. Inflammation3▲ 2.3×18 topics
  16. Aging3▲ 8.7×3 topics
  17. Antimicrobial3▲ 16×4 topics
  18. Tumor Microenvironment3▲ 9.3×6 topics
  19. AAV2▲ 102×1 topic
  20. Apoptosis2▲ 13×8 topics
  21. Viral Vectors2▲ 102×1 topic
  22. Autophagy2▲ 74×2 topics
  23. Cellular Functions2▲ 54×3 topics
  24. Therapeutic Applications2▲ 70×2 topics
  25. Biogenic Amines2▲ 85×1 topic
  26. Cancer Treatment2▲ 15×4 topics
  27. Chemotherapy2▲ 5.3×10 topics
  28. Polyamines2▲ 278×1 topic
  29. Photosensitizers2▲ 153×1 topic
  30. Singlet Oxygen2▲ 153×1 topic
  31. Fluorescence Imaging2▲ 23×1 topic
  32. Photothermal Therapy2▲ 27×1 topic
  33. Tumor Metastasis2▲ 58×2 topics
  34. Cell Division2▲ 119×1 topic
  35. Microtubules2▲ 119×1 topic
  36. Regulation2▲ 5.2×4 topics
  37. Transcriptional Regulation2▲ 16×6 topics
  38. Cancer Stem Cells2▲ 55×1 topic
  39. Epithelial-Mesenchymal Transition2▲ 26×1 topic
  40. Mutation2▲ 14×2 topics

Which research topics does AntiCancer (United States) publish most on?

By volume in 2022-now: Cancer Research and Treatments, Folate and B Vitamins Research, Virus-based gene therapy research and Polyamine Metabolism and Applications.

  1. 1 Cancer Research and Treatments Biotechnology 14 works
  2. 2 Folate and B Vitamins Research Rheumatology 4 works
  3. 3 Virus-based gene therapy research Genetics 2 works
  4. 4 Polyamine Metabolism and Applications Molecular Biology 2 works
  5. 5 Photodynamic Therapy Research Studies Pulmonary and Respiratory Medicine 2 works
  6. 6 Nanoplatforms for cancer theranostics Biomedical Engineering 2 works
  7. 7 Microtubule and mitosis dynamics Cell Biology 2 works
  8. 8 Cancer Cells and Metastasis Oncology 2 works
  9. 9 Cancer-related Molecular Pathways Oncology 1 works
  10. 10 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.6%not open66.4%

World: 40% of research is openly available.

with international co-authors44.7%domestic only55.3%

World: 18% is written across borders.

How has AntiCancer (United States)'s research output changed?

Output in 2022-2025 was 36% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is AntiCancer (United States) as a percentage of every work published that year, 0.00030% in 2024.

still counting0.00050%0.0010%0.0015%AntiCancer (United States)0.00024% in 202519801990200020102020

Fractional works of AntiCancer (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

5%10%15%all institutions10.0% in 2020AntiCancer (United States)8.6% in 20202020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 14.6% in 2012.

Other research institutions in San Diego

All research institutions in San Diego

Share AntiCancer (United States)'s ranking

AntiCancer (United States) on Science Explorer

A card with AntiCancer (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about AntiCancer (United States). Posts are plain text and can be reported.